Information

Tipoline approved in China: the world's first d...

Obstructive sleep apnea (OSA) is a chronic disease characterized by repeated nocturnal apnea. About 425 million people worldwide suffer from it, of which 176 million are in China. For a...

A new option for long-term blood sugar control ...

For patients with type 2 diabetes, long-term medication to control blood sugar is a big challenge. Traditional hypoglycemic drugs need to be taken multiple times a day, which is not...

Beware! Five types of people who should never t...

Lemborexant is a new insomnia treatment drug that has attracted much attention in recent years. It has become a new choice for many insomnia patients due to its unique mechanism...

Guide to using Lepore during the growth period:...

"Will this sleeping pill be addictive?" "After taking Lebrexan for a month, will my insomnia become worse if I suddenly stop taking it?" As a new type of orexin receptor...

Beware! A complete guide to the risks of drug i...

As the clinical application of GLP-1 drugs in the field of glucose reduction and weight loss continues to heat up, the new generation of dual receptor agonist Tirzepatide has attracted...

Traditional hypoglycemic drugs have poor effect...

🔍 Three major dilemmas of traditional hypoglycemic drugs The 2023 China Diabetes Diagnosis and Treatment Survey shows that among patients using traditional glucose-lowering drugs: ● 42% of people are troubled...